J
Jeremiah G. Tilles
Researcher at University of California, Irvine
Publications - 62
Citations - 2541
Jeremiah G. Tilles is an academic researcher from University of California, Irvine. The author has contributed to research in topics: Virus & Interferon. The author has an hindex of 26, co-authored 62 publications receiving 2487 citations.
Papers
More filters
Journal ArticleDOI
In vitro effects of echinacea and ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome patients
TL;DR: Extracts of Echinacea purpurea and Panax ginseng enhance cellular immune function of PBMC both from normal individuals and patients with depressed cellular immunity.
Journal ArticleDOI
A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group.
S A Bozzette,R A Larsen,J Chiu,Mary Ann E. Leal,J Jacobsen,P Rothman,P Robinson,G Gilbert,McCutchan Ja,Jeremiah G. Tilles +9 more
TL;DR: In patients with AIDS, silent persistent infection is common after clinically successful treatment for cryptococcal meningitis, and maintenance therapy with fluconazole is highly effective in preventing recurrent cryptococ CAL infection.
Journal ArticleDOI
Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin.
J Chiu,J Nussbaum,Samuel A. Bozzette,Jeremiah G. Tilles,L S Young,John M. Leedom,Peter N.R. Heseltine,J A McCutchan +7 more
TL;DR: Mycobacterial load and systemic symptoms in patients with AIDS and disseminated M. avium complex infection can be effectively reduced by a regimen containing amikacin, ethambutol, rifampin, and ciprofloxacin.
Journal ArticleDOI
Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Rifampin, ethambutol, clofazimine, and ciprofloxacin. The California Collaborative Treatment Group.
Carol A. Kemper,Tze-Chiang Meng,J Nussbaum,J Chiu,D. F. Feigal,Angie E. Bartok,John M. Leedom,Jeremiah G. Tilles,Stanley C. Deresinski,McCutchan Ja +9 more
TL;DR: In this article, a phase II, multicenter clinical trial was conducted to determine the quantitative microbiologic response and clinical response of patients with Mycobacterium avium complex bacteremia and AIDS to an oral antimycobacterial regimen.
Journal ArticleDOI
Antibody-Dependent Cellular Cytotoxicity Independently Predicts Survival in Severely Immunocompromised Human Immunodeficiency Virus-Infected Patients
Donald N. Forthal,Gary Landucci,Richard Haubrich,Bobi Keenan,Baruch D. Kuppermann,Jeremiah G. Tilles,Jonathan E. Kaplan +6 more
TL;DR: ADCC may be an important determinant of disease progression independently of anti-retroviral therapy, CD4 cell count, and HIV RNA and remains significantly associated with a lower risk of death.